randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 - Annals Neurology Erythropoietin in amyotrophic lateral sclerosis:
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double blinded placebo controlled trial ScienceDirect Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet Retrospective observational study on the use of acetyl l carnitine in ALS Journal of Neurology Springer Nature Link
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2


00262-4/asset/89dd934c-f271-4a89-9f55-b9a4707e82c0/main.assets/gr3_lrg.jpg)
